JPMorgan Upgrades Bruker Corp to $90 Target Price

JPMorgan Elevates Bruker Corporation to Overweight with $90 Price Target

In a decisive market move, JPMorgan has upgraded Bruker Corporation (NASDAQ:BRKR), a key player in the analytical instrumentation industry, from Neutral to Overweight, adjusting the price target from $60 to an ambitious $90. This upgrade follows Bruker's announcement of an impressive fourth quarter performance and an optimistic 2024 guidance that surpassed market expectations.